• Bortezomib - National Cancer Institute

      www.cancer.gov/about-cancer/treatment/drugs/bortezomib FDA Approval for Bortezomib. Use in Cancer. Bortezomib is approved to treat: Multiple myeloma. Mantle cell lymphoma in patients who have already received at least one ...
    • Bortezomib - Proteasome inhibitor for cancer

      bortezomib.org Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome. This drug is thought to inhibit many proteins (known as ...
    • Velcade (Bortezomib) Drug Information: Description, User ...

      www.rxlist.com/velcade-drug.htm Learn about the prescription medication Velcade (Bortezomib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
    • Bortezomib: MedlinePlus Drug Information

      www.nlm.nih.gov/medlineplus/druginfo/meds/a607007.html Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other ...
    • Bortezomib - Drug Information - Chemocare

      chemocare.com/chemotherapy/drug-info/bortezomib.aspx (bore TEZ oh mib) Trade name: Velcade ® Chemocare.com uses generic names in all descriptions of drugs. Velcade is the trade name for Bortezomib.
    • Bortezomib (Professional Patient Advice) - Drugs.com

      www.drugs.com/ppa/bortezomib.html Professional guide for Bortezomib. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
    • Bortezomib (Velcade) | Cancer Research UK

      www.cancerresearchuk.org/about-cancer/cancers-in-general/.../bortezomib The biological therapy drug bortezomib (Velcade) is a treatment for myeloma. The possible side effects include feeling or being sick; tiredness; weakness; diarrhoea ...